Bindra S, Mostafa E, Abdelgawad M, Selim S, Kumar S, Mathew B
RSC Med Chem. 2025; .
PMID: 39925735
PMC: 11799932.
DOI: 10.1039/d4md00837e.
Pan J, Dong Y, Zou Z, Gu T, Chen L, Li K
Physiol Rep. 2024; 12(24):e70091.
PMID: 39725655
PMC: 11671244.
DOI: 10.14814/phy2.70091.
Secci D, Sanna E, Distinto S, Onali A, Lupia A, Demuru L
Molecules. 2024; 29(18).
PMID: 39339439
PMC: 11433937.
DOI: 10.3390/molecules29184444.
Dai T, Wang Q, Zhu L, Luo Q, Yang J, Meng X
Int J Nanomedicine. 2024; 19:8519-8540.
PMID: 39185349
PMC: 11345023.
DOI: 10.2147/IJN.S459960.
Braconi L, Riganti C, Parenti A, Cecchi M, Nocentini A, Bartolucci G
Molecules. 2024; 29(14).
PMID: 39064868
PMC: 11279465.
DOI: 10.3390/molecules29143290.
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity.
Aslan H, Renzi G, Angeli A, DAgostino I, Ronca R, Massardi M
RSC Med Chem. 2024; 15(6):1929-1941.
PMID: 38911163
PMC: 11187566.
DOI: 10.1039/d4md00101j.
Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition.
Nocentini A, Di Porzio A, Bonardi A, Bazzicalupi C, Petreni A, Biver T
J Enzyme Inhib Med Chem. 2024; 39(1):2366236.
PMID: 38905127
PMC: 11195807.
DOI: 10.1080/14756366.2024.2366236.
Discovery of water-soluble semicarbazide-containing sulfonamide derivatives possessing favorable anti-glaucoma effect and drug-like properties.
Xie Y, Wang X, Jia H, Chu N
Saudi Pharm J. 2024; 32(3):101969.
PMID: 38328793
PMC: 10848004.
DOI: 10.1016/j.jsps.2024.101969.
Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application.
El-Azab A, Abdel-Aziz A, Bua S, Nocentini A, Bakheit A, Alkahtani H
Saudi Pharm J. 2023; 31(12):101866.
PMID: 38033749
PMC: 10682911.
DOI: 10.1016/j.jsps.2023.101866.
2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.
Sequeira L, Distinto S, Meleddu R, Gaspari M, Angeli A, Cottiglia F
J Enzyme Inhib Med Chem. 2023; 38(1):2270183.
PMID: 37870190
PMC: 11003494.
DOI: 10.1080/14756366.2023.2270183.
Tail-approach based design, synthesis, and cytotoxic evaluation of novel disubstituted and trisubstituted 1,3-thiazole benzenesulfonamide derivatives with suggested carbonic anhydrase IX inhibition mechanism.
Bondock S, Albarqi T, Abboud M, Nasr T, Mohamed N, Abdou M
RSC Adv. 2023; 13(34):24003-24022.
PMID: 37577088
PMC: 10413337.
DOI: 10.1039/d3ra02528d.
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors.
Peerzada M, Vullo D, Paoletti N, Bonardi A, Gratteri P, Supuran C
ACS Med Chem Lett. 2023; 14(6):810-819.
PMID: 37312840
PMC: 10258898.
DOI: 10.1021/acsmedchemlett.3c00094.
Effect of hydrophobic extension of aryl enaminones and pyrazole-linked compounds combined with sulphonamide, sulfaguanidine, or carboxylic acid functionalities on carbonic anhydrase inhibitory potency and selectivity.
Abdelrasheed Allam H, Albakry M, Mahmoud W, Bonardi A, Moussa S, Mohamady S
J Enzyme Inhib Med Chem. 2023; 38(1):2201403.
PMID: 37078174
PMC: 10120533.
DOI: 10.1080/14756366.2023.2201403.
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
Angeli A, Paoletti N, Supuran C
Molecules. 2023; 28(7).
PMID: 37049983
PMC: 10096498.
DOI: 10.3390/molecules28073220.
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors.
Astrain-Redin N, Paoletti N, Plano D, Bonardi A, Gratteri P, Angeli A
J Enzyme Inhib Med Chem. 2023; 38(1):2191165.
PMID: 36938694
PMC: 10035951.
DOI: 10.1080/14756366.2023.2191165.
Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII.
Fiorentino F, Nocentini A, Rotili D, Supuran C, Mai A
J Enzyme Inhib Med Chem. 2023; 38(1):2188147.
PMID: 36912265
PMC: 10013323.
DOI: 10.1080/14756366.2023.2188147.
Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties.
Tekeli T, Akocak S, Petreni A, Lolak N, Cete S, Supuran C
J Enzyme Inhib Med Chem. 2023; 38(1):2185762.
PMID: 36880350
PMC: 9987750.
DOI: 10.1080/14756366.2023.2185762.
Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review.
Alkhayal Z, Shinwari Z, Gaafar A, Alaiya A
Curr Issues Mol Biol. 2023; 45(2):1373-1386.
PMID: 36826034
PMC: 9954968.
DOI: 10.3390/cimb45020089.
Indisulam Reduces Viability and Regulates Apoptotic Gene Expression in Pediatric High-Grade Glioma Cells.
Moncao C, Scrideli C, Andrade A, Viapiano M, Carlotti C, Moreno D
Biomedicines. 2023; 11(1).
PMID: 36672576
PMC: 9855339.
DOI: 10.3390/biomedicines11010068.
Biochemical and inhibition of bovine and human carbonic anhydrase-II by 1H-1,2,3-triazole analogs.
Khan M, Avula S, Ahsan Halim S, Waqas M, Asmari M, Khan A
Front Chem. 2022; 10:1072337.
PMID: 36505753
PMC: 9732439.
DOI: 10.3389/fchem.2022.1072337.